1Willemze R,Jaffe ES,Burg G. WHO-EORTC classification for cutaneous lymphomas[J].Blood,2005.3768-3785.
2Servitje O,Gallardo F,Estrach T. Primary cutaneous marginal zone B-cell lymphoma:a clinical,histopathological,immunophenotypic and molecular genetic study of 22 cases[J].British Journal of Dermatology,2002.1147-1158.
3Cho-Vega JH,Vega F,Rassidakis G. Primary cutan-eous marginal zone B-Cell lymphoma[J].American Journal of Clinical Pathology,2006.S38-S49.
4Chan NPY,Lam WY. Primary cutaneous marginal zone B-cell lymphoma,Hong Kong[J].Journal of Dermatology and Venereology,2006.87-91.
7Hoefnagel JJ,Vermeer MH,Jansen PM. Primary cutaneous marginal zone B-Cell lymphoma clinical and therapeutic features in 50 cases[J].Archives of Dermatology,2005.1139-1145.
8Conconi A,Martinelli G,Catherine Thiéblemont C. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type[J].Blood,2003.2741-2745.
二级参考文献26
1Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues[ M ]. Lyon : IARC Press, 2001. 119- 126.
2Cogliatti SB, Schmid U. Who is WHO and what was REAL [ J ]? Swiss Med Wkly, 2002,132(43 - 44) : 607 - 617.
3Thieblemont C, Coiffier B. Management of marginal zone lymphomas [J]. Curr Treat Options Oncol, 2006, 7(3):213 - 222.
4Cohen SM, Petryk M, Varma M, et al. Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue [ J ]. Oncologist, 2006, 11 ( 10 ) : 1100- 1117.
6Willemze R. Primary cutaneous B-cell lymphoma: classification and treatment[J]. Curr Opin Oncol, 2006, 18(5) : 425 - 431.
7Philip EL, Gtmter B, David W, et al. Who Health Organization Classification of Tumors: Pathology and genetics of skin tumors [ M ]. Lyon: IARC Press, 2001. 194 - 199.
8Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas [ J ]. Blood, 2005,105 (10) : 3768 - 3785.
9Servitje O, Gallardo F, Esterach T, et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases[J]. Bri J Dernatol, 2002,147(6): 1147- 1158.
10Tsuji K, Suzuki D, Naito Y, et al. Primary cutaneous marginal zone B-cell lymphoma[J]. Eur J Dermatol, 2005, 15 (6) : 480 - 483.
